Medco Research to explore uses of genetic biomarkers; Study explores role of proteins as biomarker for colon cancer

>  The Medco Research Institute and SureGene are collaborating on new research that sheds light on the connection between variations in genetic biomarkers and the efficacy of antipsychotic therapies. Report

> A new study explores the role of hydrophobic proteins as biomarkers for colon cancer. Release

> The FDA has selected Ariana Pharma's Knowledge Extraction Management decision-support platform for biomarker signature validation work. Ariana release

> The Biomedical Advanced Research and Development Authority awarded Menssana Research a contract for $4.2 million plus options--which could total $22.84 million, if exercised--to develop a breath test for radiation exposure. Menssana Research has developed a breathalyzer which can detect several hundred different chemical compounds in normal human breath. Menssana release

> Emerald BioStructures and SomaLogic will collaborate on new technology needed to design and optimize SOMAmers for use in diagnostics and biomarker discovery. Story